Scleroderma primary prevention

Jump to navigation Jump to search

Scleroderma Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Scleroderma from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Study of Choice

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

X Ray

CT

MRI

Echocardiography or Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Scleroderma primary prevention On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Scleroderma primary prevention

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Scleroderma primary prevention

CDC on Scleroderma primary prevention

Scleroderma primary prevention in the news

Blogs on Scleroderma primary prevention

Directions to Hospitals Treating Scleroderma

Risk calculators and risk factors for Scleroderma primary prevention

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: M. Khurram Afzal, MD [2]

Overview

Effective measures for the primary prevention of scleroderma include avoiding occupational and environmental exposure to crystalline silica, epoxy resins, welding fumes and hand-arm vibration.

Primary Prevention

References

  1. Diot E, Lesire V, Guilmot JL, Metzger MD, Pilore R, Rogier S, Stadler M, Diot P, Lemarie E, Lasfargues G (August 2002). "Systemic sclerosis and occupational risk factors: a case-control study". Occup Environ Med. 59 (8): 545–9. PMC 1740346. PMID 12151611.
  2. Barnes J, Mayes MD (March 2012). "Epidemiology of systemic sclerosis: incidence, prevalence, survival, risk factors, malignancy, and environmental triggers". Curr Opin Rheumatol. 24 (2): 165–70. doi:10.1097/BOR.0b013e32834ff2e8. PMID 22269658.
  3. 3.0 3.1 Dospinescu P, Jones GT, Basu N (March 2013). "Environmental risk factors in systemic sclerosis". Curr Opin Rheumatol. 25 (2): 179–83. doi:10.1097/BOR.0b013e32835cfc2d. PMID 23287382.
  4. Marie I, Gehanno JF, Bubenheim M, Duval-Modeste AB, Joly P, Dominique S, Bravard P, Noël D, Cailleux AF, Weber J, Lagoutte P, Benichou J, Levesque H (February 2014). "Prospective study to evaluate the association between systemic sclerosis and occupational exposure and review of the literature". Autoimmun Rev. 13 (2): 151–6. doi:10.1016/j.autrev.2013.10.002. PMID 24129037.
  5. De Martinis M, Ciccarelli F, Sirufo MM, Ginaldi L (2016). "An overview of environmental risk factors in systemic sclerosis". Expert Rev Clin Immunol. 12 (4): 465–78. doi:10.1586/1744666X.2016.1125782. PMID 26610037.

Template:WH Template:WS